A study conducted in a mouse glioblastoma model proved that LAG-3 inhibition with a blocking antibody is efficacious against glioblastoma and can be used in combination with other immune checkpoint inhibitors toward the complete eradication of model glioblastoma tumors [45]. The gene discussed is LAG3; the disease is glioblastoma.